<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ContentLora: Health and medicine</title><description>New and updated Health and medicine pages on ContentLora.</description><link>https://contentlora.com/</link><language>en</language><atom:link href="https://contentlora.com/topics/health/feed.xml" rel="self" type="application/rss+xml"/><item><title>Alnylam Pharmaceuticals</title><link>https://contentlora.com/wiki/alnylam-pharmaceuticals/</link><guid isPermaLink="true">https://contentlora.com/wiki/alnylam-pharmaceuticals/</guid><description>Alnylam developed the first approved RNAi drug and is a major siRNA drugmaker. Its medicines, the Amvuttra heart approval and its 2026 pipeline.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item><item><title>Altos Labs</title><link>https://contentlora.com/wiki/altos-labs/</link><guid isPermaLink="true">https://contentlora.com/wiki/altos-labs/</guid><description>Altos Labs is a cell-rejuvenation biotech launched in 2022 with US$3 billion. Its mission, sites, leadership and where it fits in aging research.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Antibody-drug conjugates (ADCs)</title><link>https://contentlora.com/wiki/antibody-drug-conjugates/</link><guid isPermaLink="true">https://contentlora.com/wiki/antibody-drug-conjugates/</guid><description>Antibody-drug conjugates link an antibody to a toxic payload. Not immunotherapy themselves, they are increasingly paired with checkpoint inhibitors.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>Base editing</title><link>https://contentlora.com/wiki/base-editing/</link><guid isPermaLink="true">https://contentlora.com/wiki/base-editing/</guid><description>Base editing rewrites a single DNA letter without cutting both strands. How it works, the first patients treated, and pivotal trials in 2026.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>BioNTech</title><link>https://contentlora.com/wiki/biontech/</link><guid isPermaLink="true">https://contentlora.com/wiki/biontech/</guid><description>BioNTech is the Mainz-based company that co-developed the Pfizer-BioNTech COVID-19 vaccine and is now focused on mRNA cancer immunotherapy.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item><item><title>Bispecific antibodies and T-cell engagers</title><link>https://contentlora.com/wiki/bispecific-t-cell-engagers/</link><guid isPermaLink="true">https://contentlora.com/wiki/bispecific-t-cell-engagers/</guid><description>Bispecific antibodies bind two targets at once, either linking T cells to tumours or pairing PD-1 with VEGF blockade. Approvals and 2026 trial results.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>BRAIN Initiative</title><link>https://contentlora.com/wiki/brain-initiative/</link><guid isPermaLink="true">https://contentlora.com/wiki/brain-initiative/</guid><description>The US BRAIN Initiative funds neurotechnology and brain-mapping research. Its 2013 launch, budget swings from $680 million to $320 million, and 2026 rebound.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>neurotech</category><category>life-sciences</category><category>health</category></item><item><title>CagriSema (cagrilintide and semaglutide)</title><link>https://contentlora.com/wiki/cagrisema/</link><guid isPermaLink="true">https://contentlora.com/wiki/cagrisema/</guid><description>CagriSema combines the amylin analogue cagrilintide with semaglutide. Novo Nordisk&apos;s REDEFINE results, the miss against tirzepatide and its FDA review.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>metabolic-medicine</category><category>health</category><category>life-sciences</category></item><item><title>Calico Life Sciences</title><link>https://contentlora.com/wiki/calico-life-sciences/</link><guid isPermaLink="true">https://contentlora.com/wiki/calico-life-sciences/</guid><description>Calico is the aging research company Google announced in 2013. Its mission, AbbVie partnership, pipeline and 2026 milestones.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>CAR-T cell therapy</title><link>https://contentlora.com/wiki/car-t-cell-therapy/</link><guid isPermaLink="true">https://contentlora.com/wiki/car-t-cell-therapy/</guid><description>CAR-T cell therapy: engineered T cells approved for blood cancers since 2017. Approvals, safety rules, the 2026 solid-tumour first and what comes next.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>Casgevy (exa-cel)</title><link>https://contentlora.com/wiki/casgevy/</link><guid isPermaLink="true">https://contentlora.com/wiki/casgevy/</guid><description>Casgevy is the first approved CRISPR medicine, an edited stem cell therapy for sickle cell disease and beta-thalassemia. Approvals, data and status.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>CEPI (Coalition for Epidemic Preparedness Innovations)</title><link>https://contentlora.com/wiki/cepi/</link><guid isPermaLink="true">https://contentlora.com/wiki/cepi/</guid><description>CEPI funds vaccines against epidemic threats and leads the 100 Days Mission. Its role in mRNA and pandemic preparedness, and its 2027-2031 plan.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item><item><title>CRISPR-Cas9</title><link>https://contentlora.com/wiki/crispr-cas9/</link><guid isPermaLink="true">https://contentlora.com/wiki/crispr-cas9/</guid><description>CRISPR-Cas9 is the RNA-guided DNA-cutting tool behind modern gene editing and the first approved CRISPR medicine. Origins, uses and limits.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>CRISPR Therapeutics</title><link>https://contentlora.com/wiki/crispr-therapeutics/</link><guid isPermaLink="true">https://contentlora.com/wiki/crispr-therapeutics/</guid><description>CRISPR Therapeutics is the Swiss-based gene-editing company behind Casgevy with Vertex, now running in vivo CRISPR trials in heart and liver disease.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>Eli Lilly and Company</title><link>https://contentlora.com/wiki/eli-lilly/</link><guid isPermaLink="true">https://contentlora.com/wiki/eli-lilly/</guid><description>Eli Lilly makes tirzepatide (Mounjaro, Zepbound) and the GLP-1 pill Foundayo, and is developing retatrutide. Its 2026 results, pipeline and pricing.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>metabolic-medicine</category><category>health</category><category>life-sciences</category></item><item><title>ER-100 (Life Biosciences&apos; reprogramming therapy)</title><link>https://contentlora.com/wiki/er-100/</link><guid isPermaLink="true">https://contentlora.com/wiki/er-100/</guid><description>ER-100 is the first partial epigenetic reprogramming therapy tested in people, in a Phase 1 trial in glaucoma and NAION. Design, early data and caveats.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Immune checkpoint inhibitors</title><link>https://contentlora.com/wiki/immune-checkpoint-inhibitors/</link><guid isPermaLink="true">https://contentlora.com/wiki/immune-checkpoint-inhibitors/</guid><description>Checkpoint inhibitors such as pembrolizumab release immune brakes like PD-1 and CTLA-4. How they work, who responds, side effects and 2026 approvals.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>In vivo CAR-T</title><link>https://contentlora.com/wiki/in-vivo-car-t/</link><guid isPermaLink="true">https://contentlora.com/wiki/in-vivo-car-t/</guid><description>In vivo CAR-T aims to make CAR-T cells inside the body with one infusion, skipping cell manufacturing. Early 2025-2026 myeloma data, safety and limits.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>Intellia Therapeutics</title><link>https://contentlora.com/wiki/intellia-therapeutics/</link><guid isPermaLink="true">https://contentlora.com/wiki/intellia-therapeutics/</guid><description>Intellia Therapeutics develops in vivo CRISPR therapies. Lonvo-z for hereditary angioedema is under FDA review; nex-z trials resumed after a 2025 hold.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>NIA Interventions Testing Program (ITP)</title><link>https://contentlora.com/wiki/interventions-testing-program/</link><guid isPermaLink="true">https://contentlora.com/wiki/interventions-testing-program/</guid><description>The NIA Interventions Testing Program tests candidate anti-aging compounds in genetically diverse mice at multiple sites. Its design and key results.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Intismeran autogene (mRNA-4157/V940)</title><link>https://contentlora.com/wiki/intismeran-autogene/</link><guid isPermaLink="true">https://contentlora.com/wiki/intismeran-autogene/</guid><description>Intismeran autogene is Moderna and Merck&apos;s personalised mRNA cancer therapy. What it is and its 2026 phase 3 melanoma results.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item><item><title>Lipid nanoparticle delivery for gene editing</title><link>https://contentlora.com/wiki/lipid-nanoparticle-delivery/</link><guid isPermaLink="true">https://contentlora.com/wiki/lipid-nanoparticle-delivery/</guid><description>Lipid nanoparticles carry CRISPR and base-editor instructions into the liver. How they work in gene editing, key trials and their limits.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>LOY-002 (Loyal&apos;s senior dog lifespan drug)</title><link>https://contentlora.com/wiki/loy-002/</link><guid isPermaLink="true">https://contentlora.com/wiki/loy-002/</guid><description>LOY-002 is Loyal&apos;s daily pill meant to extend senior dogs&apos; lifespan. Its FDA status, the 1,300-dog STAY study and what remains before a decision.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Moderna</title><link>https://contentlora.com/wiki/moderna/</link><guid isPermaLink="true">https://contentlora.com/wiki/moderna/</guid><description>Moderna is the Cambridge, Massachusetts mRNA company behind Spikevax and the first mRNA flu vaccine. Its products, pipeline and 2026 position.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item><item><title>Neuralink</title><link>https://contentlora.com/wiki/neuralink/</link><guid isPermaLink="true">https://contentlora.com/wiki/neuralink/</guid><description>Neuralink develops the N1, a wireless brain implant placed by a surgical robot. Its trials, reported results, safety record and what remains unproven.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>neurotech</category><category>health</category><category>life-sciences</category></item><item><title>Novo Nordisk</title><link>https://contentlora.com/wiki/novo-nordisk/</link><guid isPermaLink="true">https://contentlora.com/wiki/novo-nordisk/</guid><description>Novo Nordisk is the Danish maker of semaglutide (Ozempic, Wegovy, Wegovy pill). Its GLP-1 history, 2025–2026 results, pipeline and pricing pressures.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>metabolic-medicine</category><category>health</category><category>life-sciences</category></item><item><title>Orforglipron (Foundayo)</title><link>https://contentlora.com/wiki/orforglipron/</link><guid isPermaLink="true">https://contentlora.com/wiki/orforglipron/</guid><description>Orforglipron (Foundayo) is Eli Lilly&apos;s once-daily small-molecule GLP-1 pill, FDA-approved for weight management in April 2026. Trial data and pricing.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>metabolic-medicine</category><category>health</category><category>life-sciences</category></item><item><title>Paradromics</title><link>https://contentlora.com/wiki/paradromics/</link><guid isPermaLink="true">https://contentlora.com/wiki/paradromics/</guid><description>Paradromics builds Connexus, a fully implanted high-channel brain-computer interface for restoring speech. Its FDA-approved trial and first results.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>neurotech</category><category>health</category><category>life-sciences</category></item><item><title>Partial reprogramming</title><link>https://contentlora.com/wiki/partial-reprogramming/</link><guid isPermaLink="true">https://contentlora.com/wiki/partial-reprogramming/</guid><description>Partial reprogramming uses Yamanaka factors briefly to make cells act younger without erasing their identity. The evidence, risks and first human trial.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Personalized (bespoke) gene editing</title><link>https://contentlora.com/wiki/personalized-gene-editing/</link><guid isPermaLink="true">https://contentlora.com/wiki/personalized-gene-editing/</guid><description>Personalized gene editing builds an editor for one patient&apos;s mutation. The 2025 CPS1 case, how it was made and how the FDA plans to regulate it.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>Personalised mRNA neoantigen vaccines</title><link>https://contentlora.com/wiki/personalized-neoantigen-vaccines/</link><guid isPermaLink="true">https://contentlora.com/wiki/personalized-neoantigen-vaccines/</guid><description>Individualised mRNA cancer vaccines such as intismeran autogene and autogene cevumeran: how they work, the 2026 phase 3 win and the setbacks.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>Precision Neuroscience</title><link>https://contentlora.com/wiki/precision-neuroscience/</link><guid isPermaLink="true">https://contentlora.com/wiki/precision-neuroscience/</guid><description>Precision Neuroscience makes Layer 7, a thin-film brain surface array with 1,024 electrodes and FDA clearance for up to 30 days of implantation.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>neurotech</category><category>health</category><category>life-sciences</category></item><item><title>Prime editing</title><link>https://contentlora.com/wiki/prime-editing/</link><guid isPermaLink="true">https://contentlora.com/wiki/prime-editing/</guid><description>Prime editing is a &quot;search-and-replace&quot; gene-editing method. How it works, the first human data in 2025, and the road to a first filing.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>gene-editing</category><category>life-sciences</category><category>health</category></item><item><title>Rapamycin and mTOR inhibition</title><link>https://contentlora.com/wiki/rapamycin-and-mtor/</link><guid isPermaLink="true">https://contentlora.com/wiki/rapamycin-and-mtor/</guid><description>Rapamycin blocks the mTOR growth pathway and extends lifespan in mice. The animal evidence, human trials such as PEARL, and open questions.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Retatrutide</title><link>https://contentlora.com/wiki/retatrutide/</link><guid isPermaLink="true">https://contentlora.com/wiki/retatrutide/</guid><description>Retatrutide is Eli Lilly&apos;s investigational GIP, GLP-1 and glucagon triple agonist. Phase 2 and TRIUMPH phase 3 results and its 2027 filing plan.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>metabolic-medicine</category><category>health</category><category>life-sciences</category></item><item><title>Self-amplifying RNA (saRNA)</title><link>https://contentlora.com/wiki/self-amplifying-rna/</link><guid isPermaLink="true">https://contentlora.com/wiki/self-amplifying-rna/</guid><description>Self-amplifying RNA vaccines carry a viral copying enzyme so the RNA multiplies inside cells. How saRNA works and its first approvals.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item><item><title>Semaglutide</title><link>https://contentlora.com/wiki/semaglutide/</link><guid isPermaLink="true">https://contentlora.com/wiki/semaglutide/</guid><description>Semaglutide (Ozempic, Wegovy, Rybelsus, Wegovy pill) is Novo Nordisk&apos;s GLP-1 drug. Its trials, approvals, oral forms, prices and patent status in 2026.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>metabolic-medicine</category><category>health</category><category>life-sciences</category></item><item><title>Senolytics</title><link>https://contentlora.com/wiki/senolytics/</link><guid isPermaLink="true">https://contentlora.com/wiki/senolytics/</guid><description>Senolytics are drugs designed to clear senescent cells. What they are, the mouse evidence, and how human trials have fared as of 2026.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Speech neuroprostheses</title><link>https://contentlora.com/wiki/speech-neuroprostheses/</link><guid isPermaLink="true">https://contentlora.com/wiki/speech-neuroprostheses/</guid><description>Speech neuroprostheses decode attempted speech from the brain into text or a synthetic voice for people with paralysis. Key results, limits and trials.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>neurotech</category><category>health</category><category>life-sciences</category></item><item><title>Synchron</title><link>https://contentlora.com/wiki/synchron/</link><guid isPermaLink="true">https://contentlora.com/wiki/synchron/</guid><description>Synchron&apos;s Stentrode is a brain-computer interface delivered through the blood vessels, avoiding open-brain surgery. Its trials, safety data and plans.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>neurotech</category><category>health</category><category>life-sciences</category></item><item><title>TAME trial (Targeting Aging with Metformin)</title><link>https://contentlora.com/wiki/tame-trial/</link><guid isPermaLink="true">https://contentlora.com/wiki/tame-trial/</guid><description>TAME is a proposed trial of the diabetes drug metformin designed to test whether a drug can delay aging-related diseases. Its design, history and status.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>longevity</category><category>life-sciences</category><category>health</category></item><item><title>Tirzepatide</title><link>https://contentlora.com/wiki/tirzepatide/</link><guid isPermaLink="true">https://contentlora.com/wiki/tirzepatide/</guid><description>Tirzepatide (Mounjaro, Zepbound) is Eli Lilly&apos;s dual GIP/GLP-1 agonist. Its trials, approvals, head-to-head data, sales and pricing as of 2026.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>metabolic-medicine</category><category>health</category><category>life-sciences</category></item><item><title>Tumour-infiltrating lymphocyte (TIL) therapy</title><link>https://contentlora.com/wiki/tumor-infiltrating-lymphocyte-therapy/</link><guid isPermaLink="true">https://contentlora.com/wiki/tumor-infiltrating-lymphocyte-therapy/</guid><description>TIL therapy grows a patient&apos;s own tumour-derived T cells and infuses them back. The 2024 FDA approval of lifileucel, results and open questions.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>Utah array</title><link>https://contentlora.com/wiki/utah-array/</link><guid isPermaLink="true">https://contentlora.com/wiki/utah-array/</guid><description>The Utah array is a grid of microelectrodes pushed into the cortex. It powered most landmark BCI studies, from cursor control in 2006 to speech in 2024.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Wiki</category><category>neurotech</category><category>health</category><category>life-sciences</category></item><item><title>Cancer immunotherapy tracker: approvals and trial results</title><link>https://contentlora.com/events/cancer-immunotherapy-tracker/</link><guid isPermaLink="true">https://contentlora.com/events/cancer-immunotherapy-tracker/</guid><description>A dated, sourced timeline of cancer immunotherapy milestones from 2024 to October 2026: approvals, phase 3 readouts, safety actions and setbacks.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Developing</category><category>cancer-immunotherapy</category><category>health</category><category>life-sciences</category></item><item><title>Gene editing tracker: approvals, trials and setbacks</title><link>https://contentlora.com/events/gene-editing-tracker/</link><guid isPermaLink="true">https://contentlora.com/events/gene-editing-tracker/</guid><description>A dated, sourced timeline of gene-editing milestones: Casgevy approvals, in vivo CRISPR trials, base and prime editing, FDA actions and safety events.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Developing</category><category>gene-editing</category><category>health</category><category>life-sciences</category></item><item><title>Longevity research tracker: aging biology milestones</title><link>https://contentlora.com/events/longevity-tracker/</link><guid isPermaLink="true">https://contentlora.com/events/longevity-tracker/</guid><description>A live tracker of aging and longevity research: reprogramming trials, dog lifespan drugs, senolytic and rapamycin trials, clocks and prizes.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Developing</category><category>longevity</category><category>health</category><category>life-sciences</category></item><item><title>GLP-1 and metabolic medicine tracker</title><link>https://contentlora.com/events/metabolic-medicine-tracker/</link><guid isPermaLink="true">https://contentlora.com/events/metabolic-medicine-tracker/</guid><description>Live tracker of GLP-1 and obesity-medicine milestones: approvals, pills, triple agonists, outcome trials, Medicare coverage and pricing, 2023–2026.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Developing</category><category>metabolic-medicine</category><category>health</category><category>life-sciences</category></item><item><title>Neurotech tracker: brain-computer interfaces and brain mapping</title><link>https://contentlora.com/events/neurotech-tracker/</link><guid isPermaLink="true">https://contentlora.com/events/neurotech-tracker/</guid><description>A dated timeline of brain-computer interface trials, approvals, speech neuroprostheses, connectome milestones and neural-data rules, 2024 to October 2026.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Developing</category><category>neurotech</category><category>health</category><category>life-sciences</category></item><item><title>mRNA vaccines and RNA medicines tracker</title><link>https://contentlora.com/events/vaccines-mrna-tracker/</link><guid isPermaLink="true">https://contentlora.com/events/vaccines-mrna-tracker/</guid><description>A dated, sourced timeline of mRNA vaccine, self-amplifying RNA and RNA-drug milestones and US policy changes, updated as the field moves.</description><pubDate>Sat, 10 Oct 2026 00:00:00 GMT</pubDate><category>Developing</category><category>vaccines-mrna</category><category>health</category><category>life-sciences</category></item></channel></rss>